⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML

Official Title: Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML; Multi Center Therapy Concept

Study ID: NCT00606723

Study Description

Brief Summary: 1. To evaluate whether stem cell transplantation from a matched sibling donor is equivalent to a matched unrelated donor in in a second complete remission of acute myeloid leukemia (AML). 2. To evaluate whether stem cell transplantation (SCT) after chemotherapy (FLAMSA-schema) increases survival compared to a threshold derived from historical data 3. To evaluate whether SCT from haploidentical donors for children having no matched donor will result in better survival with acceptable toxicity.

Detailed Description: Target variables: * Treatment response * Event Free Survival * Leukemia Free Survival * Graft Versus Host Disease * Regimen related toxicity

Eligibility

Minimum Age:

Eligible Ages: CHILD, ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Graz University Hospital, Graz, , Austria

Innsbruck University Hospital, Innsbruck, , Austria

St. Anna Children Hospital, Wien, , Austria

Teaching Hospital Motol, Prag, , Czechia

University Hospital Freiburg, Freiburg, Baden-Württemberg, Germany

Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany

University Children's Hospital Tübingen, Tübingen, Baden-Württemberg, Germany

University Children's Hospital Ulm, Ulm, Baden-Württemberg, Germany

University Children's Hospital Erlangen-Nürnberg, Erlangen, Bavaria, Germany

Dr. von Haunersches Kinderspital, München, Bavaria, Germany

University Hospital Würzburg, Würzburg, Bavaria, Germany

J.W. Goethe University Hospital and Faculty of Medicine, Frankfurt, Hesse, Germany

Gießen University Hospital, Gießen, Hesse, Germany

Hannover Medical School, Department of Paediatrics, Paediatric Hematology and Oncology, Hannover, Lower Saxony, Germany

University Hospital Greifswald, Greifswald, Mecklenburg-West Pomerania, Germany

Düsseldorf University Hospital, Düsseldorf, North Rhine-Westphalia, Germany

University Hospital Essen, Essen, North Rhine-Westphalia, Germany

Münster University Hospital, Münster, North Rhine-Westphalia, Germany

University Children's Hospital Halle, Halle, Saxony-Anhalt, Germany

Carl Gustav Carus University Children's Hospital Dresden, Dresden, Saxony, Germany

University Hospital Kiel, Kiel, Schleswig-Holstein, Germany

University Children's Hospital Jena, Jena, Thuringia, Germany

Charité Campus Rudolf Virchow Hospital, Berlin, , Germany

Hamburg-Eppendorf University Hospital, Hamburg, , Germany

Contact Details

Name: Martin Sauer, Prof. Dr.

Affiliation: Hannover Medical School

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: